LLS IMPACT RESEARCH GRANTS:
Bringing new treatment options to you
LLS IMPACT RESEARCH GRANTS:
Bringing new treatment options to you
The Leukemia & Lymphoma Society (LLS) believes nothing should stand between you and your care.
We want every blood cancer patient to benefit from the latest advances in treatment. Clinical trials are avenues to world-class care and might be the best treatment option for you. But we realize you may have concerns about travel, costs, and other issues. In addition, cultural differences, language barriers, and fear and distrust of the medical system may be on your mind. We’re here to help you navigate clinical trials so that you, your family, and your community are part of the quest for cures.
Breaking Down Clinical Trial Myths & Misperceptions
Myth vs. Fact
FACT: Clinical trials are carefully designed research studies that put the health and safety of patients first. Before you agree to participate, you’ll be taken through the informed consent process. You’ll be able to gather information and ask questions. You have the right to have the consent thoroughly explained to you if you don’t understand something. Participation in a clinical trial is always up to you, and you can leave the study at any time.
FACT: Clinical trials are for patients at all stages of their disease and treatment. By taking part, you’ll join a team of doctors and patients who share your desire to improve cancer treatment now and in the future. Treatment decisions are very personal, so make sure to discuss your options with your doctor.
FACT: Many people are concerned about getting a placebo (an inactive pill, liquid, or powder). The vast majority of cancer clinical trials do not use a placebo unless given along with an active drug. If a trial uses a placebo, you will be made aware through informed consent before enrolling.
FACT: Talk to your doctor about what joining a clinical trial means for you and your loved ones. Levels of participation vary trial by trial. Some trials may require frequent trips to the hospital, and you might need childcare or time off from work. No matter what care you choose, LLS is here to provide support for you and your family.
(Remember, always consult with your doctor about your treatment options.)
Knowledge is Power.
Our LLS Clinical Trial Nurse Navigators can help you and your caregiver throughout the entire clinical trial process. For free, one-on-one support, please call (800) 955-4572 or click here.
Curing Blood Cancers Needs You
LLS is setting out to improve access to clinical trials for underrepresented patients, including Black, Indigenous, and People of Color (BIPOC), Hispanic, Latinx, and people from rural communities. Our LLS IMPACT* Research Grants award funding to three major cancer centers to partner with community-based hospitals and clinics on creating networks of clinical trial sites in their regions.
See if there’s a program near you:
IMPACT AT THE MD ANDERSON CANCER CENTER
The Clinical Trial Network of South Texas will expand access to high quality clinical trials for under-represented minority patients receiving care at the UT San Antonio Mays Cancer Center and community oncology centers leveraging the existing partnership between MD Anderson Cancer Center and its robust clinical trial infrastructure. The initial focus is on community centers in South TX, which have higher numbers of Hispanic and African American patients in rural and urban counties that experience disparities in the incidence of lymphoid cancers, access to clinical trials, and survival.More information
IMPACT AT THE UNIVERSITY OF COLORADO
The University of Colorado/UCHealth Blood Disorders Center is the only academic program serving patients with hematologic malignancies in the Rocky Mountain Region. Working with regional community oncology centers will increase enrollment of underserved populations throughout the Colorado front range major population centers (metro Denver, Fort Collins, Colorado Springs) as well as rural Colorado and the Rocky Mountain region. Working with the CU Anschutz Center for Native American Health Care will specifically address unique social and practical barriers to clinical trials participation by Native Americans in the Rocky Mountain Region.More information
IMPACT AT CITY OF HOPE:
The City of Hope Comprehensive Cancer Center main campus in Duarte, CA has a catchment area of 9,365 square miles, including Los Angeles, Orange, Ventura, Riverside, and San Bernardino counties serving a multi-racial, multi-ethnic community of 17 million people. To provide better access to state-of-the-art cancer care to all, COH has established numerous Community and Affiliate Network (CAN) sites that will serve geographically proximal practice sites, which will refer patients for treatment on clinical trials at either the CAN site or at the Duarte campus.More information
IMPACT AT MAYO CLINIC:
Mayo Clinic Cancer Center has partnered with the Minnesota Cancer Clinical Trials Network and Mayo Clinic Health System to expand clinical trial enrollment among blood cancer patients served at community cancer centers, with a focus on those generally underrepresented in trials. This project includes a network of 35 clinical sites throughout rural, underserved communities in Minnesota, Wisconsin, and Iowa, as well as metropolitan Minneapolis.More information
IMPACT AT VANDERBILT UNIVERSITY MEDICAL CENTER:
Working with the Vanderbilt Health Affiliated Network (VHAN) and Baptist Memorial Health Care Corporation (BMHCC), this IMPACT program reaches the rural South. Among the areas served are half of the counties and parishes in the Delta Regional Authority, which has some of the highest cancer rates in the U.S. The program will increase access, with the option to enroll in 10 clinical trials across seven blood cancer types that will be open at nine Baptist locations around the region.More information
IMPACT AT WEILL CORNELL MEDICINE:
More than half of the annual blood cancer cases in New York City are among residents of Queens and Brooklyn. Direct access to clinical trials is limited at community hospitals in these boroughs. This IMPACT project, also supported by Genentech, is working with New York-Presbyterian Queens and New York-Presbyterian Brooklyn Methodist Hospital to increase enrollment at these sites. The program will provide education and training for community physicians and oncologists.More information
Your clinical trial participation can help you, your loved ones, and your community. Contact LLS Information Specialists at (800) 955-4572 or click here to learn more.
*Influential Medicine Providing Access to Clinical Trials (IMPACT)
The choice to join a clinical trial is yours.
But you don’t have to decide alone. LLS is here to help with the free resources and support you and your loved ones may need.
Free One-on-One Support
Our Information Specialists are highly trained oncology professionals who provide free, personalized assistance to patients, families and healthcare providers. Our Information Specialists offer guidance through cancer treatment, financial and social challenges, and give accurate, up-to-date disease, treatment and support information.
Our Clinical Trial Nurse Navigators are registered nurses with expertise in blood cancers who conduct comprehensive clinical trial searches and personally assist patients, parents and caregivers throughout the entire clinical trial process.
FIND MORE INFORMATION & RESOURCES
We thank our incredible supporters for making the LLS IMPACT Research Grants program possible.
- Bristol Myers Squibb
- Cal Turner, Jr.
- Edward J. Phillips Family Foundation
- Eli Lilly and Company
- Louise and John Bryan
- Mayo Clinic
- MorphoSys Foundation
- Rahr Corporation
- Royalty Pharma
- Weill Cornell Medicine